Popular New York Times columnist made weed waves this week when she flew to Denver, ate sixteen times the recommended dose of a marijuana edible and had a bad trip wherein she thought she had died.
Twitter is rightfully mocking her apparent lack of common sense.
Here is a professional New York media figure who parachuted into Denver specifically to riff on the implementation of legalization and its chief issue — that some people are eating way more pot brownies than they should and having bad experiences.
It’s in the genes.
Researchers at the University of South Carolina have another clue as to why patients with auto-immune diseases like multiple sclerosis, psoriasis, rheumatoid arthritis, Crohn’s and celiac disease sometimes respond to medical marijuana therapies, according to Science World Reports.
The British Journal of Pharmacology has published a paper that concludes that the ingredients in marijuana likely work to prevent the onset of Alzheimer's disease, Parkinson's disease, Huntington's disease, and age-related dementia.
Smoking, vaping, or eating the pot molecules THC and CBD directly effects nerve cell function, resulting in reduced chronic brain inflammation, reduced oxidative stress, and reduced cellular dysfunction — all the while promoting stability of the human body's internal environment (homeostasis) and healthy brain cells (neurotrophic support).
An unprecedented human trial of vaporized cannabis is set to begin this summer at San Francisco General Hospital, Legalization Nation has learned.
Pending final clearances, SF General Hospital Chief of Hematology and Oncology Dr. Donald Abrams will use government dollars and government-supplied weed to see if cannabis reduces the pain and inflammation associated with sickle-cell disease. Such scientific studies are extremely rare, because of the ongoing federal war on marijuana.
The roughly 2.5 million people in the world who suffer from multiple sclerosis — an inflammatory disease of the nerves — might be surprised to learn the hippies were right: Cannabis treats symptoms of multiple sclerosis, the journal Neurology concluded Monday.
Cannabis — which the federal government calls “marijuana” — is “effective” “for reducing patient-centered measures” of spasticity in M.S. sufferers.
California police who want to ban doctors from recommending concentrated marijuana might want to talk to UCLA Professor Mark Kleiman, or mega-celebrity and cohost of The View, Whoopi Goldberg. This week, both offered resounding endorsements of portable micro-vaporizers combined with concentrated cannabis oil (wax, BHO) whether for recreational or medical use.
About 1 percent of the population is addicted to a drug that gives them headaches if they quit, and may cause jitters, anxiety, insomnia, and ulcers if they don’t. It's lethal at high doses. About 90 percent of the US population takes this drug regularly, even though it has no medical use. It’s marketed to kids, sold in or near schools, and is on school playgrounds. A schedule 1 narcotic, you assume?
Nope - caffeine.
Eight months ago CNN Chief Medical Correspondent Sanjay Gupta made a major about-face, moving from denouncing the idea of legalizing marijuana to arguing for its medical availability to anyone it helps, including children with chronic, severe seizures that do not respond to pharmaceutical drugs.
Next week, he releases ‘Cannabis Madness’ — a counterpoint to the infamous propaganda video ‘Reefer Madness’.
The anti-inflammatory properties of marijuana might help slow the lifelong process of acquiring Alzheimer’s Disease — to the point where tokers die of old age before they get dementia.
That’s the controversial findings of a professor of neuroscience, immunology, and medical genetics at Ohio State University, Gary Wenk, who says the federal drug war is blocking deeper research into cannabis' impacts on brain disease.
The Bay Area continues to lead the way in medical marijuana, this time at UCSF, where researchers are giving a compound derived from pot to kids with chronic, incurable seizure disorders.
In January, UCSF researchers began administering the marijuana-derived drug Epidiolex to seriously sick kids, some of whom were suffering ninety seizures per day. Such uncontrollable seizures often lead to brain damage and death.